PER
Click for more information
2.44% 8.0¢ percheron therapeutics limited

Ann: First Patient Dosed in ATL1102 Phase IIb DMD Trial, page-18

  1. Quay Street
    471 Posts.
    lightbulb Created with Sketch. 58
    clock Created with Sketch.
    08/06/23
    14:07
    Post #: 68197006
    Im a bit confused about ATL1102 and needs for Animal Dosing and Toxicology trials.
    ATL1102 was used years ago for the MS study, where it was proved to be effective, but apparently not a commercial goer.
    It may be because of the age of the current test subjects but the safety and toxicology should be the same.
    Anyone know?
    QS
    ANP Price at posting: 6.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Appliances and furnishings impress - will Harvey Norman be next?
right-arrow Created with Sketch.
WNX Wellnex sees first special access scheme prescriptions for new Wellness Life brand
right-arrow Created with Sketch.
G88 Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results
right-arrow Created with Sketch.
MOV MOVE Logistics picks new interim CEO to take over operations from early September
right-arrow Created with Sketch.
IMD IMDEX to receive $10M in out-of-court settlement with Boart Longyear over downhole tool patent
right-arrow Created with Sketch.
AWJ Jeffrey's Find delivered $6.3M in gold sales for August, says Auric
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.002(2.44%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.3¢ 8.4¢ 8.0¢ $58.49K 703.3K

Buyers (Bids)

No. Vol. Price($)
2 127624 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.4¢ 25545 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.